ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharma drug development biotech

Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
How Vesselon Can Improve the Entire Class of Antibody-Drug Conjugates
Clayton Larsen - President & CEO, Vesselon, Inc. | Oct 30, 2023 | 4 min read
Vesselon’s novel co-formulation of gas lipid microspheres and self-assembling liposomes, targeted and activated by commercial ultrasound, would be an ideal adjunct to any of these ADC drugs.
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015 | 1 min read
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Merck Snaps Up Biotech for $3.85B
Tracy Vence | Jun 10, 2014 | 1 min read
The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.
Shire Buys Rare Disease Drug Developer
Tracy Vence | Nov 2, 2015 | 1 min read
The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.
Opinion: A Big Pharma Biotech Fund
Mark Kessel | Mar 5, 2012 | 4 min read
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Opinion: On the Up and Up
Sean E. Harper | Jun 20, 2012 | 2 min read
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
computing a cure
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

Run a Search

ADVERTISEMENT